Skip to main content

Neutrophil-to-lymphocyte ratio (NLR) predicts mortality in hospitalized geriatric patients independent of the admission diagnosis: a multicenter prospective cohort study



The Neutrophil-to-lymphocyte ratio (NLR) is a marker of poor prognosis in hospitalized older patients with different diseases, but there is still no consensus on the optimal cut-off value to identify older patients at high-risk of in-hospital mortality. Therefore, in this study we aimed at both validating NLR as a predictor of death in older hospitalized patients and assess whether the presence of specific acute diseases can modify its predictive value.


This prospective cohort study included 5034 hospitalizations of older patients admitted to acute care units in the context of the ReportAge study. NLR measured at admission was considered as the exposure variable, while in-hospital mortality was the outcome of the study. ROC curves with Youden’s method and restricted cubic splines were used to identify the optimal NLR cut-off of increased risk. Cox proportional hazard models, stratified analyses, and Kaplan–Meier survival curves were used to analyse the association between NLR and in-hospital mortality.


Both continuous and categorical NLR value (cut-off ≥ 7.95) predicted mortality in bivariate and multivariate prognostic models with a good predictive accuracy. The magnitude of this association was even higher in patients without sepsis, congestive heart failure, and pneumonia, and those with higher eGFR, albumin, and hemoglobin (p < 0.001). A negative multiplicative interaction was found between NLR and eGFR < 45 (p = 0.001).


NLR at admission is a readily available and cost-effective biomarker that could improve identification of geriatric patients at high risk of death during hospital stay independent of admitting diagnosis, kidney function and hemoglobin levels.


Medical progress in the management of acute diseases has reduced overall hospital death rate, that however, is high in geriatric patients. Predictors of prognosis for use in routine clinical practice are an urgent need for geriatric hospitalized patients. Since neutrophils and lymphocytes represent the larger percentage of all the immune cells circulating in the bloodstream, the neutrophil/lymphocyte ratio (NLR) is a simple index of inflammation. NLR is characterized by a progressive increase in the first years of life, and then remains at similar levels during healthy aging. NLR increased values are associated with lifestyle and environmental stressors impacting on immune system [1]. Increasing evidence strongly support the association between increased NLR values and a variety of pathological conditions characterized by a proinflammatory status. NLR increased values were observed in infectious diseases, such as acute exacerbations of chronic obstructive pulmonary disease [2], pneumonia [3], COVID-19 [4, 5] and sepsis [6], and non-infectious diseases, including atherosclerotic coronary artery disease (CAD) [7, 8], stroke [9], neurodegenerative diseases [10], cancers [11, 12], kidney diseases [13], and acute kidney injury (AKI) [14]. In all these conditions, NLR is emerging as a biomarker of disease severity and for mortality risk estimation. While a large body of literature highlighted the prognostic potential of the NLR, the translation of this promising marker into the clinical setting remains highly challenging as the strength of association between NLR and overall survival varies between published studies. Although there are still no consensually accepted normal values for this parameter, there is a proposal to consider an interval of 1–2 as a normal value, an interval of 2–3 as a grey area indicating subclinical inflammation and values above 3 as inflammation [15]. NLR measurement is cheap and easily available through patients’ baseline and routine investigation of complete blood count [16]. NLR can be a universally available and inexpensive prognostic marker. Despite evidence of strong prognostic potential, no conclusive results were provided on the optimal cut-off value defining high-risk NLR. Furthermore, limited understanding of the strength of association between NLR and clinical outcomes in specific patient subgroups are limiting the adoption of the NLR as a tool for prognosis or clinical decision making. Identifying patients for whom the NLR harbors maximum prognostic potential and suggesting corresponding group-specific cut-offs for high NLR, is a challenge. However, geriatric patients are characterized by conditions such as multi-morbidity and frailty [17, 18], and hospitalized geriatric patients are extremely heterogenous. In this work, we aimed to a) verify NLR relevance as prognostic indicator of short-term mortality in geriatric patients at the time of hospital admission; b) investigate the effect modification of admission diagnosis and laboratory abnormalities on the association between NLR and mortality. The present study in a large prospective cohort of hospitalized older patients may facilitate the prospective clinical validation of the NLR as a tool for mortality risk stratification in geriatric hospitalized patients and assess its prognostic importance independent of admission diagnosis.

Materials and methods

Study population

In this study, we used data derived from the Report-AGE project, a large-scale observational study on the health conditions of older adults’ patients (over 65 years) admitted to the acute care wards of the Italian National Institute of Health and Science on Ageing (IRCCS INRCA) [19] (Trial Registration no. NCT01397682).

Briefly, all patients consecutively admitted to participating wards from September 2011 to October 2021 were asked to participate. After obtaining written informed consent, all patients underwent comprehensive geriatric assessment (CGA) by Inter-RAI Minimum Data Set acute care (MDS-AC) [20] conducted both at the time of hospitalization and at discharge. Criteria for inclusion were age ≥ 65 years, length of stay more than 24 h, and signed informed consent. Only patients affected by hematological cancers and COVID-19 were excluded. Routine laboratory parameters were available for 5, hospitalizations (4020 subjects and 1014 repeated hospitalizations). Participating physicians and nurses were specifically trained before starting recruitment, as previously described [17, 21]. Data on disease history of all patients recruited for this study were obtained from the medical records. The main acute and chronic diseases at hospital admission were coded in accordance with the International Classification of Diseases, 9th revision ( Multimorbidity was measured by Charlson Comorbidity Index [22].

Laboratory parameters

Laboratory parameters measured at hospital admission included blood cell counts, creatinine, albumin, hemoglobin, and aspartate aminotransferase/alanine aminotransferase (AST/ALT), and were assessed with standardized procedures. eGFR was calculated by using BIS Equation [23]:

$${\text{BIS1 eGFR}}\, = \,{3},{736}\, \times \,{\text{S}}_{{{\text{Cr}}}}^{{{-}0.{87}}} \, \times \,{\text{age}}^{{{-}0.{95}}} [ \times \,0.{\text{82 if women}}]$$

where SCr=serum creatinine.

Hypoalbuminemia was defined as having serum albumin levels < 3.5 g/dL.


Outcome measure of interest was in-hospital death. Patients were followed from hospital admission until died in hospital or discharged alive. Length of hospital stay was calculated as the time from the patient’s admission to the acute care unit until discharged or died in the hospital.

Statistical analysis

Means with standard deviations were used to describe continuous variables with normal distribution (assessed with Shapiro–Wilk test); absolute frequencies and percentages were used for categorical variables.

The Chi-square test and the Student’s t test were performed to compare variables between groups (survived vs deceased patients), as appropriate. One-way ANOVA with post-hoc Bonferroni test for multiple comparisons were used to evaluate differences in mean NLR levels between patients with distinct diseases at hospital admission. In order to identify the NLR cut-off of increased risk in our population we followed a two-step approach; first, we applied the Receiver operating characteristics (ROC) curve analysis with Youden’s method to maximize the sum of sensitivity and specificity; second, to examine the possibility of non-linear associations between NLR and study outcomes, we used restricted cubic splines with best knots placed at 25th, 50th, and 75th percentile of NLR distribution. NLR was then dichotomized according to the identified cut-off and its association with in-hospital mortality was inspected by using Kaplan-Meyer curves and cox regression analyses. To account for sex differences in identified cut-offs, we also performed weighted ROC curve analysis and sex-specific restricted cubic splines. The association of both continuous and categorical NLR with in-hospital mortality was then assessed by using bivariate and multivariate Cox regression models; Model 1 was adjusted for age and sex; Model 2 was adjusted for age, sex, main diagnoses at hospital admission and Charlson index; Model 3 was adjusted for age, sex, eGFR, albumin, hemoglobin, and AST/ALT; Model 4 was adjusted for age, sex, main diagnoses, Charlson index, eGFR, albumin, hemoglobin, AST/ALT. We finally examined the possible effect modification in the baseline categorical NLR-mortality association across strata of clinical and laboratory values.

All the analyses were performed with SPSS 25.0 (IBM, Chicago, IL, USA), Stata 15.1 (StataCorp LP, College Station, TX, USA), and R 4.6. P values less than 0.05 (two-sided) were considered statistically significant.


Demographic, clinical and laboratory characteristics of hospitalizations included in the present analysis are reported in Additional file 1. Overall, the 5,034 patients included in the study had a mean age of 86.6 ± 6.4 years, were more commonly women (57.5%), with a Charlson index ≥ 2 (55.2%), and a mean length of stay of more than 9 days. During the hospital stay, 611 out of 5,034 hospitalizations led to death (12.1%). Patients who died were significantly older, had a higher prevalence of several acute diseases, including sepsis, lung infections, cardiac arrhythmias and heart failure, as well as a lower glomerular filtration rate compared to those who survived. As regards the laboratory values, mean levels of NLR, AST, ALT, white blood cells (WBC), and creatinine were significantly higher in deceased patients; conversely, albumin and hemoglobin levels were significantly lower. As regards the NLR distribution, median [interquartile range, IQR] NLR values were 5.9 [3.3–11.4] and were also significantly higher in deceased patients (11.0 [6.0–22.0]) compared to survived ones (5.5 [3.1–10.3]).

NLR mean values were explored in the overall population and in patients with specific diseases at hospital admission (Table 1). Patients with sepsis and lung infections had the highest NLR values, followed by those with metabolism disorders and diabetes, heart diseases, and gastrointestinal pathologies; similar results were shown in analyses reporting median and IQR instead of mean (SD) values (Additional file 2); one-way ANOVA with Bonferroni post-hoc test showed significant differences in NLR mean levels depending on the main cause for hospital admission (Additional file 3). The most significant differences were observed between patients with sepsis, pneumonia, and cerebrovascular diseases compared to those affected by other diagnoses.

Table 1 NLR (mean and standard deviation) for the main diagnosis at hospital admission

Cut-off points of NLR for increased risk of in-hospital death were substantially coincident when performing ROC analysis with Youden’s method and spline regression models (Fig. 1). Indeed, ROC analysis identified in 7.95 the NLR cut-off value able to efficiently capture the patient’s risk of death with a sensitivity of 66% and specificity of 65%; the predictive accuracy was good (AUC = 0.707; 95%CI 0.686–0.728). The analysis of the association between NLR and death through restricted cubic splines highlighted the non-linear dose–response relationship; in patients with NLR above the threshold of 7.95, the risk of death increased progressively but becomes quasi-exponential in NLR range between 7.95 and 35. Similar findings were shown in sex-stratified analyses (Additional file 5: Fig. S1a, Additional file 6: Fig. S1b, and Additional file 7: Fig. S1c).

Fig. 1
figure 1

Selection of the optimal cut-off of NLR for increased risk of in-hospital mortality. Selection of the optimal cut-off of NLR by using ROC curve analysis with Youden’s method (A) and restricted cubic spline with 3 knots (B). Red ticks on x-axis represent quartiles of NLR distribution

Survival analysis using Kaplan Meier curves showed that patients with NLR ≥ 7.95 had an increased risk of in-hospital death compared to those with lower NLR levels (Fig. 2, log rank p < 0.001). Similar findings were reported after stratifying by sex of included patients (Additional file 8: Fig. S2a and Additional file 9: Fig. S2b).

Fig. 2
figure 2

Kaplan Meier survival estimates for dichotomized NLR in the overall study population

Cox regression analysis showed that continuous NLR was significantly associated with in-hospital mortality in both bivariate and all multivariate models; furthermore, after categorization, NLR ≥ 7.95 was shown to be significantly associated with study outcomes in all regression models (Table 2).

Table 2 Cox regression analysis showing the bivariate and multivariate association between NLR and death

To assess the effect modification of distinct diseases and laboratory values on the association between NLR and study outcome, we performed stratified cox regression models reported in Additional file 4. Association between NLR (both continuous and categorical) and death was found to be consistent across all diseases and lab abnormalities, but, interestingly, predictive accuracy was found to be higher and slightly more pronounced in patients without high-risk acute conditions (e.g. sepsis, pneumonia, and congestive heart failure), and among those with more preserved kidney function, normal albumin levels and normal hemoglobin (Additional file 4). Also, a multiplicative age and sex-adjusted negative interaction was found between continuous NLR and eGFR on mortality risk (p = 0.041) and between categorical NLR and eGFR < 45 ml/min/1.73 m2 (p < 0.001). Indeed, despite NLR was shown to progressively increase with eGFR decline and both variables predict mortality in fully adjusted models, they negatively interacted in predicting death. Furthermore, NLR/BIS ratio was associated with death with a higher strength in patients with eGFR ≥ 45 (fully adjusted HR: 4.80, 2.61–8.83) compared to eGFR < 45 (fully adjusted HR: 1.55, 1.36–1.77, p < 0.001). These results were also confirmed in fully-adjusted models containing a 4-level analytical variable including categories of NLR (< and ≥ 7.95) and eGFR (< and ≥ 45 ml/min/1.73 m2). Indeed, compared with patients with eGFR < 45 and NLR < 7.95, those with eGFR ≥ 45 and NLR ≥ 7.95 were characterized by an increased risk of death in fully adjusted models A and B, and in C and D fully adjusted models not containing albumin (p < 0.001).


In this retrospective study of 5,034 consecutive older patients, we investigated the association between NLR—assessed at admission—and in-hospital mortality. We showed that patients deceased during the hospital stay had a significantly higher NLR compared to those who survived. Furthermore, despite several acute conditions significantly contributed to patient’s hospital admission and prognosis, NLR predictive ability was independent from the admission diagnosis and was even better in patients without critical illnesses and in those with preserved hemoglobin and renal function. Finally, a negative multiplicative negative interaction was found between NLR and GFR. To the best of our knowledge, this is the first study assessing the predictive value of NLR in hospitalized geriatric patients independently of the admission diagnosis and across a large spectrum of disease states and laboratory parameters. Analysis of the NLR values according to the main diagnoses revealed significant differences among conditions, with sepsis and pneumonia displaying the highest values Despite the high heterogeneity observed according to the main diagnosis, we were able to obtain a single NLR cutoff of 7.95, which was able to predict in-hospital mortality independent of the admission diagnosis, age, sex, comorbidities, and other biochemical confounders. Previous studies evaluated the prognostic value of NLR in hospitalized patients, mostly in specific diseases or conditions [24,25,26]. While a substantial agreement has been reached on the association between high NLR and poor outcomes, a high heterogeneity of the proposed cutoffs has been highlighted [24, 27,28,29]. In our population, we observed a relatively high mean NLR of 9.5, which could be related to pre-existing comorbidities, most of which are accompanied by the chronic low-grade proinflammatory status that characterizes age-related diseases [30]. The detrimental role of heightened inflammation and depressed adaptive immunity is evident not only in infectious diseases, where most of the studies on NLR have focused, but also in other non-communicable disorders, where the persistence of chronic inflammation could accelerate organ damage (e.g. type 2 diabetes), prevent functional recovery (e.g. major cardiovascular events), or promote cancer progression. In this framework, NLR could be considered as a proxy measure of the imbalance between innate and acquired immunity which has been identified as a major feature of immunosenescence and determinant of inflammaging [31].

Albeit we showed that a single NLR cutoff applies to a highly heterogeneous population of older patients, we recognize the importance of interpreting NLR values also as a continuous variable. Indeed, we reported a linear relationship between NLR values < 40 and mortality risk, which was further confirmed by the multivariable analysis, that resulted in an additional 2% mortality risk for each 1-point increase of NLR. These results suggest that NLR provides an easy-to-interpret outcome predictor but that specific cutoff values should be computed according to different clinical settings.

In a secondary analysis, we performed multiple stratifications according to the presence of specific diagnoses and the levels of laboratory variables that were used to infer the general condition of the patients at the time of admission, such as eGFR, albumin, and hemoglobin, which are associated with mortality [32, 33]. The survival analysis revealed that the discriminatory ability of NLR was consistently higher in those patients without diseases characterized by the highest mortality rates and NLR values, including sepsis, pneumonia, heart failure, and with absence of either hypoalbuminemia, impaired renal function, or anemia. The observed results could be explained by the wider distribution of NLR in patients without the conditions associated with the highest NLR values, which invariably increases its ability of effectively discriminate patients according to their survival status. While increasing attention has been devoted to NLR in patients with acute conditions, such as sepsis, myocardial infarction, and COVID-19, our results remark on the importance of assessing this parameter also in non-critical settings. This is further confirmed by the negative interaction found between NLR and eGFR; indeed, whereas both increasing NLR and decreasing eGFR were significantly associated with mortality in fully-adjusted models, their prognostic interaction was negative and multiplicative in both categorical and continuous models. More in detail, patients with eGFR ≥ 45 ml/min/1.73 m2 and high NLR shared a significant higher risk of death compared to those with eGFR < 45 and normal NLR, thus underlining the importance of considering NLR in addition to eGFR in stratifying the prognosis of older patients in the acute care setting, where the evaluation of eGFR only could be biased by rapid changes of serum creatinine during hospital stay [34, 35].

The major strengths of our study are the large sample size, the specific focus on a population of older subjects (age > 80 yrs.), and the inclusion of all patients admitted to hospital during the observation period, which minimized the risk of selection bias. Moreover, we provided evidence that a variable obtained at no additional cost could improve the predictive ability of the other routinely assessed biomarkers, including eGFR.

Some limitations have to be highlighted. First, our analysis relied on a single blood cell count, which did not allow us to explore potential relationships between fluctuations of NLR during hospital stay and study outcome. In this regard, repeated measurements of NLR during the in-hospital stay may provide additional prognostic information. Second, diagnosis of diseases was retrospectively derived from ICD-9 codes, with potential underestimation of disease prevalence at hospital admission; third, we could not include sensitive measures of disease severity which may improve prognostic risk stratification in hospitalized older patients. However, our study has also several strengths, such as the large sample size, the prospective study design, the comprehensive characterization of hospitalized older patients, and the use of multiple statistical approaches to test the predictive accuracy of NLR across a wide range of disease conditions.


In our study, we showed that a readily available and cost-effective biomarker such as NLR could provide additional guidance in identifying geriatric patients at higher risk of death during their in-hospital stay already at the time of admission. As a future development, other indices derived from the complete blood count, as well as the study of the additional parameters provided by most hematology analyzer manufacturers reflecting immune cell differentiation and activation, could expand, with limited efforts, the set of predictive biomarkers available for risk stratification.

Availability of data and materials

Anonymised data and code used in conducting the analyses will be made available upon request directed to the corresponding author.



Acute kidney injury


Alanine aminotransferase


Aspartate aminotransferase


Coronary artery disease


Comprehensive geriatric assessment


Confidence interval


Estimated glomerular filtration rate


Interquartile range


Hazard ratio


Minimum data set acute care


Neutrophil-to-lymphocyte ratio


Receiver operating characteristic


White blood cells


  1. Pellegrino R, Paganelli R, Iorio AD, Bandinelli S, Moretti A, Iolascon G, et al. Temporal trends, sex differences, and age-related disease influence in neutrophil, lymphocyte count and neutrophil to lymphocyte-ratio. Results from InCHIANTI follow-up study. Res Sq. 2023.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Feng X, Xiao H, Duan Y, Li Q, Ou X. Prognostic value of neutrophil to lymphocyte ratio for predicting 90-day poor outcomes in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2023;18:1219–30.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kakehi E, Uehira R, Ohara N, Akamatsu Y, Osaka T, Sakurai S, et al. Utility of the New Early Warning Score (NEWS) in combination with the neutrophil-lymphocyte ratio for the prediction of prognosis in older patients with pneumonia. Fam Med Community Health. 2023.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Regolo M, Sorce A, Vaccaro M, Colaci M, Stancanelli B, Natoli G, et al. Assessing humoral immuno-inflammatory pathways associated with respiratory failure in COVID-19 patients. J Clin Med. 2023.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020;18(1):206.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ru S, Luo Y. The association and prognostic value of systemic inflammatory response index with short and long-term mortality in patients with sepsis. Medicine. 2023;102(29):e33967.

    Article  CAS  PubMed  Google Scholar 

  7. Dentali F, Nigro O, Squizzato A, Gianni M, Zuretti F, Grandi AM, et al. Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: a systematic review and meta-analysis of the literature. Int J Cardiol. 2018;266:31–7.

    Article  PubMed  Google Scholar 

  8. Dong CH, Wang ZM, Chen SY. Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: a systematic review and meta-analysis. Clin Biochem. 2018;52:131–6.

    Article  PubMed  Google Scholar 

  9. Su X, Zhao S, Zhang N. Admission NLPR predicts long-term mortality in patients with acute ischemic stroke: a retrospective analysis of the MIMIC-III database. PLoS ONE. 2023;18(8):e0283356.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Yu ZW, Wang Y, Li X, Tong XW, Zhang YT, Gao XY. Association between the neutrophil to lymphocyte ratio and mild cognitive impairment in patients with type 2 diabetes. Aging Clin Exp Res. 2023;35(6):1339–45.

    Article  PubMed  Google Scholar 

  11. Zhang W, Tan Y, Li Y, Liu J. Neutrophil to Lymphocyte ratio as a predictor for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Front Immunol. 2023;14:1234142.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Guida M, Bartolomeo N, Quaresmini D, Quaglino P, Madonna G, Pigozzo J, et al. Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma. J Transl Med. 2022;20(1):159.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Moh MC, Low S, Shao YM, Subramaniam T, Sum CF, Lim SC. Association between neutrophil/lymphocyte ratio and kidney impairment in type 2 diabetes mellitus: a role of extracellular water/total body water ratio. Diabetes Res Clin Pract. 2023;199:110634.

    Article  CAS  PubMed  Google Scholar 

  14. Wei W, Huang X, Yang L, Li J, Liu C, Pu Y, et al. Neutrophil-to-lymphocyte ratio as a prognostic marker of mortality and disease severity in septic acute kidney injury patients: a retrospective study. Int Immunopharmacol. 2023;116:109778.

    Article  CAS  PubMed  Google Scholar 

  15. Kourilovitch M, Galarza-Maldonado C. Could a simple biomarker as neutrophil-to-lymphocyte ratio reflect complex processes orchestrated by neutrophils? J Transl Autoimmun. 2023;6:100159.

    Article  CAS  PubMed  Google Scholar 

  16. Adamstein NH, Ridker PM. The neutrophil-lymphocyte ratio: considerations for clinical application. Eur Heart J. 2021;42(22):2216–7.

    Article  PubMed  Google Scholar 

  17. Corsonello A, Soraci L, Di Rosa M, Bustacchini S, Bonfigli AR, Lisa R, et al. Prognostic interplay of functional status and multimorbidity among older patients discharged from hospital. J Am Med Dir Assoc. 2022;23(3):499–5061.

    Article  PubMed  Google Scholar 

  18. Vetrano DL, Palmer K, Marengoni A, Marzetti E, Lattanzio F, Roller-Wirnsberger R, et al. Frailty and multimorbidity: a systematic review and meta-analysis. J Gerontol A Biol Sci Med Sci. 2019;74(5):659–66.

    Article  PubMed  Google Scholar 

  19. Bustacchini S, Abbatecola AM, Bonfigli AR, Chiatti C, Corsonello A, Di Stefano G, et al. The report-AGE project: a permanent epidemiological observatory to identify clinical and biological markers of health outcomes in elderly hospitalized patients in Italy. Aging Clin Exp Res. 2015;27(6):893–901.

    Article  PubMed  Google Scholar 

  20. Gray LC, Bernabei R, Berg K, Finne-Soveri H, Fries BE, Hirdes JP, et al. Standardizing assessment of elderly people in acute care: the interRAI acute care instrument. J Am Geriatr Soc. 2008;56(3):536–41.

    Article  PubMed  Google Scholar 

  21. Gagliardi C, Corsonello A, Di Rosa M, Fabbietti P, Cherubini A, Mercante O, et al. Preadmission functional decline predicts functional improvement among older patients admitted to acute care hospital. J Gerontol A Biol Sci Med Sci. 2018;73(10):1363–9.

    Article  PubMed  Google Scholar 

  22. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.

    Article  CAS  PubMed  Google Scholar 

  23. Schaeffner ES, Ebert N, Delanaye P, Frei U, Gaedeke J, Jakob O, et al. Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med. 2012;157(7):471–81.

    Article  PubMed  Google Scholar 

  24. Huang Z, Fu Z, Huang W, Huang K. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: a meta-analysis. Am J Emerg Med. 2020;38(3):641–7.

    Article  PubMed  Google Scholar 

  25. Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81(1):e6–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Ni J, Wang H, Li Y, Shu Y, Liu Y. Neutrophil to lymphocyte ratio (NLR) as a prognostic marker for in-hospital mortality of patients with sepsis: a secondary analysis based on a single-center, retrospective, cohort study. Medicine (Baltimore). 2019;98(46): e18029.

    Article  PubMed  Google Scholar 

  27. Vano YA, Oudard S, By MA, Tetu P, Thibault C, Aboudagga H, et al. Optimal cut-off for neutrophil-to-lymphocyte ratio: fact or Fantasy? A prospective cohort study in metastatic cancer patients. PLoS ONE. 2018;13(4): e0195042.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Zhao Y, Yue J, Lei P, Lin T, Peng X, Xie D, et al. Neutrophil-lymphocyte ratio as a predictor of delirium in older internal medicine patients: a prospective cohort study. BMC Geriatr. 2021;21(1):334.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Zhu Y, Bi Y, Liu B, Zhu T. Assessment of prognostic value of preoperative neutrophil-to-lymphocyte ratio for postoperative mortality and morbidity. Front Med. 2023;10:1102733.

    Article  Google Scholar 

  30. Franceschi C, Garagnani P, Morsiani C, Conte M, Santoro A, Grignolio A, et al. The Continuum of aging and age-related diseases: common mechanisms but different rates. Front Med. 2018;5:61.

    Article  Google Scholar 

  31. Olivieri F, Marchegiani F, Matacchione G, Giuliani A, Ramini D, Fazioli F, et al. Sex/gender-related differences in inflammaging. Mech Ageing Dev. 2023;211: 111792.

    Article  CAS  PubMed  Google Scholar 

  32. Abd-Elraheem M, Mashav N, Ioffe M, Kremer A, Justo D. Which laboratory malnutrition markers best predict 1-year mortality in hospitalized older adults? Eur Geriatr Med. 2019;10(4):619–24.

    Article  PubMed  Google Scholar 

  33. Zhang BF, Wang J, Wen PF, Wu YJ, Guo JB, Wang YK, et al. The association between hemoglobin at admission and mortality of older patients with hip fracture: a mean 3-year follow-up cohort study. Eur Geriatr Med. 2023;14(2):275–84.

    Article  PubMed  Google Scholar 

  34. Dumnicka P, Mazur-Laskowska M, Ceranowicz P, Sporek M, Kolber W, Tisończyk J, et al. Acute changes in serum creatinine and kinetic glomerular filtration rate estimation in early phase of acute pancreatitis. J Clin Med. 2022.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Siriwardane D, Woodman R, Hakendorf P, Martin JH, White GH, Ben-Tovim DI, et al. Stability of plasma creatinine concentrations in acute complex long-stay admissions to a general medical service. Clin Med. 2010;10(6):540–3.

    Article  Google Scholar 

Download references


A complete list of participating centers has been previously reported [19].


The Report-AGE study (NCT01397682) is partially supported by the Italian Ministry of Health (grant n. RF-2013-02358848) and Rete Aging (Fondi Ricerca Corrente Reti).

Author information

Authors and Affiliations



MDR, JS, LS, ACh, and FO conceptualised the study. MDR and LS performed the statistical analysis. MDR, JS, LS, and FO wrote the first draft of the manuscript. All authors interpreted the results, commented on and revised successive drafts of the manuscript, and approved the final version. All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.

Corresponding author

Correspondence to Luca Soraci.

Ethics declarations

Ethics approval and consent to participate

The Ethical Committee of the Italian National Research Center on Aging has approved the study protocol which was in accordance with 1964 Helsinki declaration. The trial registration number is NCT01397682. Signed informed consent was obtained from all participants in the study.

Consent for publication

Not applicable.

Competing interests

All Authors declare to have no competing interests with the content of this manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

Baseline characteristics of the study population in general and after stratifying by in-hospital status.

Additional file 2:

NLR (median and interquartile range) for the main diagnosis at hospital admission.

Additional file 3:

Comparisons of mean NLR values by main diagnosis at hospital admission (one-way ANOVA and post-Hoc Bonferroni test).

Additional file 4:

Assessment of the effect modification of diseases and lab values on the association between NLR (both continuous and categorical) and death.

Additional file 5:

Figure S1a. Optimal NLR cut-off for increased risk of in-hospital mortality in men and women. Selection of the optimal cut-off of NLR for increased risk of in-hospital mortality by using sex-weighted and age-adjusted ROC curve in the study population.

Additional file 6:

Figure S1b. Restricted cubic spline showing the non-linear relationship between NLR and in-hospital mortality among male patients. Red ticks on x-axis represent quartiles of NLR distribution.

Additional file 7:

Figure S1c. Restricted cubic spline showing the non-linear relationship between NLR and in-hospital mortality among female patients. Red ticks on x-axis represent quartiles of NLR distribution.

Additional file 8:

Figure s2a. Kaplan Meier curves showing survival of male patients according to NLR categories.

Additional file 9:

Figure s2b. Kaplan Meier curves showing survival of female patients according to NLR categories.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Di Rosa, M., Sabbatinelli, J., Soraci, L. et al. Neutrophil-to-lymphocyte ratio (NLR) predicts mortality in hospitalized geriatric patients independent of the admission diagnosis: a multicenter prospective cohort study. J Transl Med 21, 835 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: